Page: Quality aspects of phage therapy medicinal products-2025/10/24

Page: Opinions and letters of support on the qualification of novel methodologies for medicine development-2025/10/24

Document: Annex IV - Discussion meeting with applicant - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Annex I - Briefing document - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Annex III - Written responses to list of issues - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Annex II - Initial Qualification Opinion List of Issues - molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Draft qualification opinion for molecule-independent device bridging approach (MIDBA)-2025/10/24

Document: Draft guideline on quality aspects of phage therapy medicinal products-2025/10/24

Document: Clinical Trial Information System (CTIS) structured data form - Notifications, Annual Safety Report (ASR) and results-2025/10/23

Document: Minutes of the COMP meeting 9-11 September 2025-2025/10/23